RENAISSANCE TECHNOLOGIES LLC
Position in ELDN — Eledon Pharmaceuticals, Inc.
CIK 1037389
NEW YORK, NY
Position in ELDN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$791,546
+$715,778 QoQ
Shares Held
200,900
+716.7% QoQ
Ownership
0.247%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#34
of 159 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ELDN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,952,606,887 across 312 Biotechnology names. ELDN ranks #190 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,427,993 | $730,617,099 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
5,261,628 | $457,498,554 | |
| 3 | INCY |
Incyte Corp
|
3,512,132 | $398,135,283 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
320,008 | $158,957,573 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
562,073 | $135,442,730 | |
| 6 | RPRX |
Royalty Pharma plc
|
1,935,800 | $108,540,306 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,833,079 | $104,137,217 | |
| 8 | GMAB |
Genmab A/S
|
3,517,850 | $96,635,339 |
All Filings in ELDN
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $791,546 | 200,900 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $75,768 | 24,600 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $267,254 | 176,990 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $904,428 | 349,200 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $516,723 | 190,673 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $416,200 | 122,773 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $606,352 | 147,173 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $338,323 | 135,873 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $361,080 | 136,773 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $179,362 | 87,069 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $124,511 | 69,173 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $84,903 | 61,973 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $82,711 | 60,373 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $75,928 | 32,173 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $67,654 | 29,673 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $87,969 | 31,873 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $78,502 | 32,173 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $72,783 | 18,473 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $60,297 | 13,673 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $245,117 | 39,663 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $166,956 | 21,107 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $289,445 | 27,051 | Shares | Sole | 2021-05-13 | |
| No filing history on record for this holder in this stock. | ||||||